Sort by
Keyphrases
Anti-HIV-1
100%
Unnatural nucleotides
100%
HIV-1 RT
100%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
83%
Binding Pocket
50%
Inhibitor Binding
33%
Hydrophobic Residues
33%
Multidrug-resistant
33%
Drug Sensitivity
33%
Drug-resistant Variant
33%
HIV-1 Infection
33%
Hydrophobic Binding
16%
Therapeutic Intervention
16%
Structure-based Modeling
16%
Active Site mutant
16%
Design Strategy
16%
Structure-based Design
16%
Thumb
16%
Polymerase
16%
Nucleoside Inhibitors
16%
Combined Structure
16%
Viral Strains
16%
Inhibitory Potential
16%
Mutational Changes
16%
Viral Replication
16%
Inhibitory Activity
16%
Side Chain
16%
Resistance Mechanisms
16%
Binding Region
16%
Molecular Modeling
16%
Viral Infection
16%
In Vitro Assay
16%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Human Immunodeficiency Virus
100%
Lead Compound
100%
HIV
100%
Human Immunodeficiency Virus 1 Infection
50%
Virus Infection
25%
Nucleoside
25%
Virus Strain
25%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
100%
Wild Type
50%
Drug Sensitivity
25%
Virus Replication
12%
Nucleoside
12%
Polymerase
12%
Enzyme
12%
Molecular Model
12%
Crystal Structure
12%
Virus Strain
12%